Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Eulexin is FDA-approved for new indication

June 28, 1996

DepoCyt earns positive phase III results

June 28, 1996

Zithromax approved by FDA for new indication

June 28, 1996

Viramune receives accelerated FDA approval

June 28, 1996

Connective Therapeutics to develop new formulation of betamethasone valerate

June 28, 1996

Anakinra claimed for pancreatitis

June 21, 1996

FDA approval of new indication for Genentech's Activase

June 21, 1996

Mitsubishi Chem.'s Novastan receives Japanese approval for new indication

June 21, 1996

Vesnarinone treatment recommendations

June 21, 1996

Astra's Pulmicort approaches FDA approval

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...